These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 30092824)
1. Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor. Kuo KT; Huang WC; Bamodu OA; Lee WH; Wang CH; Hsiao M; Wang LS; Yeh CT Clin Epigenetics; 2018 Aug; 10(1):107. PubMed ID: 30092824 [TBL] [Abstract][Full Text] [Related]
2. JARID1B modulates lung cancer cell proliferation and invasion by regulating p53 expression. Shen X; Zhuang Z; Zhang Y; Chen Z; Shen L; Pu W; Chen L; Xu Z Tumour Biol; 2015 Sep; 36(9):7133-42. PubMed ID: 25877751 [TBL] [Abstract][Full Text] [Related]
3. JARID1B Expression Plays a Critical Role in Chemoresistance and Stem Cell-Like Phenotype of Neuroblastoma Cells. Kuo YT; Liu YL; Adebayo BO; Shih PH; Lee WH; Wang LS; Liao YF; Hsu WM; Yeh CT; Lin CM PLoS One; 2015; 10(5):e0125343. PubMed ID: 25951238 [TBL] [Abstract][Full Text] [Related]
4. KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling. Wagner KW; Alam H; Dhar SS; Giri U; Li N; Wei Y; Giri D; Cascone T; Kim JH; Ye Y; Multani AS; Chan CH; Erez B; Saigal B; Chung J; Lin HK; Wu X; Hung MC; Heymach JV; Lee MG J Clin Invest; 2013 Dec; 123(12):5231-46. PubMed ID: 24200691 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of RBP2-H1 variant of JARID1B in melanoma. Kuźbicki Ł; Lange D; Stanek-Widera A; Chwirot BW BMC Cancer; 2017 Dec; 17(1):854. PubMed ID: 29246117 [TBL] [Abstract][Full Text] [Related]
6. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma. Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection and clinicopathological significance of JARID1B/KDM5B and P16 expression in invasive ductal carcinoma of the breast. Zhao LH; Liu HG Genet Mol Res; 2015 May; 14(2):5417-26. PubMed ID: 26125737 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer. Wang L; Mao Y; Du G; He C; Han S Tumour Biol; 2015 Apr; 36(4):2465-72. PubMed ID: 25663457 [TBL] [Abstract][Full Text] [Related]
9. JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level. Huang D; Xiao F; Hao H; Hua F; Luo Z; Huang Z; Li Q; Chen S; Cheng X; Zhang X; Fang W; Hu X; Liu F Cell Commun Signal; 2020 Oct; 18(1):169. PubMed ID: 33109187 [TBL] [Abstract][Full Text] [Related]
10. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448. Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489 [TBL] [Abstract][Full Text] [Related]
11. Metformin-induced chemosensitization to cisplatin depends on P53 status and is inhibited by Jarid1b overexpression in non-small cell lung cancer cells. Tortelli TC; Tamura RE; de Souza Junqueira M; da Silva Mororó J; Bustos SO; Natalino RJM; Russell S; Désaubry L; Strauss BE; Chammas R Aging (Albany NY); 2021 Sep; 13(18):21914-21940. PubMed ID: 34528900 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia Promotes Resistance to EGFR Inhibition in NSCLC Cells via the Histone Demethylases, LSD1 and PLU-1. Lu Y; Liu Y; Oeck S; Glazer PM Mol Cancer Res; 2018 Oct; 16(10):1458-1469. PubMed ID: 29934325 [TBL] [Abstract][Full Text] [Related]
13. Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen. Sayegh J; Cao J; Zou MR; Morales A; Blair LP; Norcia M; Hoyer D; Tackett AJ; Merkel JS; Yan Q J Biol Chem; 2013 Mar; 288(13):9408-17. PubMed ID: 23408432 [TBL] [Abstract][Full Text] [Related]
14. SIRT1 is highly expressed in brain metastasis tissues of non-small cell lung cancer (NSCLC) and in positive regulation of NSCLC cell migration. Han L; Liang XH; Chen LX; Bao SM; Yan ZQ Int J Clin Exp Pathol; 2013; 6(11):2357-65. PubMed ID: 24228097 [TBL] [Abstract][Full Text] [Related]
15. Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150. Xu W; Jiang K; Shen M; Chen Y; Huang HY Oncol Rep; 2016 Jan; 35(1):352-8. PubMed ID: 26498874 [TBL] [Abstract][Full Text] [Related]
16. Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma. Fang L; Zhao J; Wang D; Zhu L; Wang J; Jiang K Int J Mol Med; 2016 Jul; 38(1):172-82. PubMed ID: 27246838 [TBL] [Abstract][Full Text] [Related]
17. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14. Li Q; Shi L; Gui B; Yu W; Wang J; Zhang D; Han X; Yao Z; Shang Y Cancer Res; 2011 Nov; 71(21):6899-908. PubMed ID: 21937684 [TBL] [Abstract][Full Text] [Related]
18. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer. Zhang Z; Yang Y; Zhang X Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645 [TBL] [Abstract][Full Text] [Related]
19. JARID1B expression and its function in DNA damage repair are tightly regulated by miRNAs in breast cancer. Mocavini I; Pippa S; Licursi V; Paci P; Trisciuoglio D; Mannironi C; Presutti C; Negri R Cancer Sci; 2019 Apr; 110(4):1232-1243. PubMed ID: 30588710 [TBL] [Abstract][Full Text] [Related]
20. Histone Demethylase JARID1B Is Overexpressed in Osteosarcoma and Upregulates Cyclin D1 Expression via Demethylation of H3K27me3. Wang W; Zheng K; Pei Y; Zhang X Oncol Res; 2018 Apr; 26(3):373-384. PubMed ID: 28492139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]